BioStem Technologies to Present at the Centri Capital Conference

Core Insights - BioStem Technologies, Inc. is a leading MedTech company specializing in placental-derived products for advanced wound care [1][3] - The CEO, Jason Matuszewski, will present at the Centri Capital Conference on April 22, 2025, at Nasdaq headquarters in New York City [1] Company Overview - BioStem Technologies focuses on the development, manufacturing, and commercialization of allografts utilizing perinatal tissue [3] - The company employs a proprietary BioREtain processing method aimed at preserving growth factors and tissue structure [3] - BioStem's quality management system is accredited by the American Association of Tissue Banks (AATB) and adheres to current Good Tissue Practices (cGTP) and Good Manufacturing Processes (cGMP) [3] - The product portfolio includes brands such as AmnioWrap™, VENDAJE, VENDAJE AC, and VENDAJE OPTIC, all processed at the FDA registered and AATB accredited facility in Pompano Beach, Florida [3]